Londinia Opportunities Analyses - 09/22/2021 (GMT) C4 THERAPEUTICS INC. - 1H
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
- U.S. Stocks
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
67%
6%
28%
My opinion
Bullish above 49.75 USD
My targets
51.16 USD (+1.77%)
52.37 USD (+4.18%)
My analysis
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on C4 THERAPEUTICS INC. as long as the price remains well above 49.75 USD. The buyers' bullish objective is set at 51.16 USD. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 52.37 USD. If there is any crossing, the next objective would be the resistance located at 54.16 USD. However, beware of bullish excesses that could lead to a possible short-term correction; but this possible correction would not be tradeable.
Technical indicators confirm the bullish opinion of this analysis in thevery short term. However, be careful of excessive bullish movements. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8
Analysis too old. There are no more charts available.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
Additional analysis
Quotes
The C4 THERAPEUTICS INC. price is 50.27 USD. The price has increased by +0.42% since the last closing and was traded between 49.54 USD and 50.36 USD over the period. The price is currently at +1.47% from its lowest and -0.18% from its highest.49.54
50.36
50.27
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by C4 THERAPEUTICS INC.:
New HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
A technical analysis in 1H of this C4 THERAPEUTICS INC. chart shows a strongly bullish trend. The signals given by the moving averages are 92.86% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
In fact, according to the parameters integrated into the Central Analyzer system, 12 technical indicators out of 18 analysed are currently bullish. Central Indicators, the scanner specialised in technical indicators, has identified these signals:
Price is back over the pivot point
Type : Bullish
Timeframe : 1 hour
Price is back over the pivot point
Type : Bullish
Timeframe : Weekly
The analysis of the price chart with Central Patterns scanners does not return any result.
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
Price
| S3 | S2 | S1 | Price | |
|---|---|---|---|---|
| ProTrendLines | 46.50 | 48.42 | 49.75 | 50.27 |
| Change (%) | -7.50% | -3.68% | -1.03% | - |
| Change | -3.77 | -1.85 | -0.52 | - |
| Level | Major | Minor | Major | - |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 46.21 | 47.21 | 48.63 | 49.63 | 51.05 | 52.05 | 53.47 |
| Camarilla | 49.40 | 49.62 | 49.84 | 50.06 | 50.28 | 50.50 | 50.73 |
| Woodie | 46.43 | 47.32 | 48.85 | 49.74 | 51.27 | 52.16 | 53.69 |
| Fibonacci | 47.21 | 48.13 | 48.70 | 49.63 | 50.55 | 51.12 | 52.05 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 45.16 | 46.37 | 48.16 | 49.37 | 51.16 | 52.37 | 54.16 |
| Camarilla | 49.13 | 49.40 | 49.68 | 49.95 | 50.23 | 50.50 | 50.78 |
| Woodie | 45.45 | 46.52 | 48.45 | 49.52 | 51.45 | 52.52 | 54.45 |
| Fibonacci | 46.37 | 47.52 | 48.22 | 49.37 | 50.52 | 51.22 | 52.37 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 20.87 | 27.67 | 33.90 | 40.70 | 46.93 | 53.73 | 59.96 |
| Camarilla | 36.55 | 37.74 | 38.94 | 40.13 | 41.32 | 42.52 | 43.71 |
| Woodie | 20.59 | 27.53 | 33.62 | 40.56 | 46.65 | 53.59 | 59.68 |
| Fibonacci | 27.67 | 32.65 | 35.72 | 40.70 | 45.68 | 48.75 | 53.73 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 58.66 | |
| MACD (12,26,9): | 0.2600 | |
| Directional Movement: | -11.22 | |
| AROON (14): | 35.72 | |
| DEMA (21): | 49.94 | |
| Parabolic SAR (0,02-0,02-0,2): | 48.22 | |
| Elder Ray (13): | 0.22 | |
| Super Trend (3,10): | 47.62 | |
| Zig ZAG (10): | 50.29 | |
| VORTEX (21): | 1.0100 | |
| Stochastique (14,3,5): | 81.59 | |
| TEMA (21): | 50.13 | |
| Williams %R (14): | -14.05 | |
| Chande Momentum Oscillator (20): | 2.19 | |
| Repulse (5,40,3): | 1.0700 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.0500 | |
| Courbe Coppock: | 4.77 |
| MA7: | 49.45 | |
| MA20: | 46.18 | |
| MA50: | 42.75 | |
| MA100: | 40.05 | |
| MAexp7: | 49.86 | |
| MAexp20: | 49.62 | |
| MAexp50: | 49.07 | |
| MAexp100: | 47.65 | |
| Price / MA7: | +1.66% | |
| Price / MA20: | +8.86% | |
| Price / MA50: | +17.59% | |
| Price / MA100: | +25.52% | |
| Price / MAexp7: | +0.82% | |
| Price / MAexp20: | +1.31% | |
| Price / MAexp50: | +2.45% | |
| Price / MAexp100: | +5.50% |
Quotes :
-
15 min delayed data
-
Actions NASDAQ
News
The latest news and videos published on C4 THERAPEUTICS INC. at the time of the analysis were as follows:
- C4 Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
- C4 Therapeutics Announces FDA Orphan Drug Designation for CFT7455 for the Treatment of Multiple Myeloma
- C4 Therapeutics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
- C4 Therapeutics Presents Pre-clinical Data on CFT7455, a Novel IKZF1/3 Degrader for the Treatment of Hematologic Malignancies, at the 16th Annual International Conference on Malignant Lymphoma
- C4 Therapeutics Announces Pricing of Public Offering